Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

908 Devices Inc. (MASS) Cash Flow Statement

908 Devices Inc. (MASS) generated $1.5M of operating cash flow over the twelve months to 2026-06-30, spent $876000 on capital expenditure and had free cash flow of $615000, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

MASS908 Devices Inc.Follow MASS — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
474.9M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
16 Nov, in 23 days
LineFY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-29.1-20.9-25.1-30.2-23.71.5
Capital expenditure0.72.02.00.61.0-0.9
Free cash flow-29.8-23.0-27.1-30.8-24.60.6
Stock-based compensation2.57.29.811.89.8—

USD millions · SEC XBRL

908 Devices Inc. — questions

What is 908 Devices Inc.'s operating cash flow?
$1.5M over the twelve months to 2026-06-30.
How much does 908 Devices Inc. spend on capital expenditure?
$876000 over the twelve months to 2026-06-30.
What is 908 Devices Inc.'s free cash flow?
$615000 over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from 908 Devices Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.